FDA backs Pfizer COVID-19 boosters for seniors, high-risk

THE FDA authorized booster doses of Pfizer's COVID-19 vaccine for Americans who are 65 and older, younger people with underlying health conditions and those in jobs that put them at high-risk for COVID-19. / AP FILE PHOTO/MATT ROURKE
The United States moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of the extra shots. The FDA authorized booster doses for Americans who are 65 and older,…

Register to keep reading or subscribe today and receive unlimited access at a special discounted rate in honor of our 35th anniversary.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display